medigraphic.com
ISSN 0185-6014 (Print)
Órgano oficial de difusión de la Federación Mexicana de Patología Clínica, AC y de la Asociación Latinoamericana de Patología Clínica/Medicina de Laboratorio

2009, Number 2

Next >>

Rev Mex Patol Clin Med Lab 2009; 56 (2)

Human influenza: A(H1N1). Update article

Barriga AG

Language: Spanish
References: 20
Page: 77-82
PDF size: 180.83 Kb.


ABSTRACT

The globalization and climate change in recent decades have led to the emergence and reemergence of many infectious agents. The current pandemic caused by A(H1N1) influenza virus, which began in our country, dramatically illustrates this phenomenon. The etiologic agent is the product of a triple genetic recombination of human, avian and swine influenza virus. A substantial number of cases have required hospitalization or died. Its diagnosis and treatment are of paramount importance because antiviral drugs are effective when they are administered within the first 48 hours of evolution. This review outlines the currently available laboratory tests, their advantages and disadvantages, the samples required, and the precautionary measures to prevent transmission to laboratory personnel responsible for obtaining and processing the samples for diagnosis.


REFERENCES

  1. Barriga AG. La globalización de las enfermedades infecciosas. Editorial. Rev Med IMSS 2003; 41 (5): 369-371.

  2. MMWRCDC. Update: Novel influenza A(H1N1) virus infections. Worldwide. MMWR 2009; 58 (17): 453-458.

  3. MMWRCDC Outbreak of swin origin influenza A(H1N1)virus infection. México, MMWR 2009; 58 (17): 467-470.

  4. Belshe RB. Implications of the emergence of a novel H1 influenza virus. New Engl J Med 2009; 10: 1056.

  5. Belshe RB. The origins of pandemic influenza. Lessons from the 1918 virus. New Engl J Med 2005; 353: 2209-2211.

  6. www.salud.gob.mx.Información Influenza. Situación actual de la epidemia, 20 de Mayo de 2009. Secretaría de Salud.

  7. Webster RG. Influenza virus: Transmission between species and relevance to emergence on the next human pandemic. Arch Virol 1997; 142 (suppl 13): 105-113.

  8. Schoenbaum SC, McNeil BJ, Kavet J. The swine influenza decision. New Engl J Med 1976; 295 (14): 759-765.

  9. Collaborative Team Influenza. Novel swine-origin influenza A (H1N1)Virus Investigation Team. Emergence of a novel swine-origin influenza A (H1N1)virus in humans. New Engl J Med 2009; 360: 2605-2615.

  10. Miller MA, Vibound C, Balinska M, Simonsen L. The signature of influenza pandemics-implications for policy. New Engl J Med 2009; 10; 1056.

  11. Brownstein JS, Freifeld CS, Madoff M. Influenza A (H1N1) Virus, 2009-Online Monitoring 2009; 10: 1056.

  12. Boonner AB, Monroe KW, Talley LI, Klasner AE, Kimberlin DW. Impact of rapid diagnosis of influenza on physician decision making and patient management. Pediatrics 2003; 112 (2): 363-367.

  13. Hurt. A. R. Lamb A.C.A. Comparison of a rapid test for influenza with laboratory based diagnosis in a pediatric population. Commun. Dis. Intell, 2005; 29 (3) 272-276.

  14. Uyeki TM, Prasad R, Vukotich Ch, Stabbins S, Rinaldo ChR, Feng Y, Morse S, et al. Low sensitivity of rapid diagnostic test for influenza. CID 2009; 48: 89-92.

  15. World Health Organization (WHO) Recommendations on the use of a rapid testing for influenza diagnosis 2005 p. 1-16.

  16. James MA. Rapid test kits for influenza OHL: Hygienic Laboratory. University of Iowa 1999; 38 (5): 3-4.

  17. Reven M, Gooseens H. Relevance of nucleic acid amplification techniques for the diagnosis of respiratory tract infections in the clinical laboratory. Clin Microbiol Rev 1997; 10 (2): 242-256.

  18. WHOCDC. Protocol for realtime RTPCR for swine influenza A(H1N1). 2009; 1-007-05: 1-8.

  19. NCCLS. Protection of laboratory workers from occupationally acquired infections: Approved Guideline 2001. 2nd ed. M-29-A2.21, 23.

  20. OSHA. Influenza preparedness and response guidance for healthcare workers and healthcare employers. 2007OSHA, 3228-3235.




2020     |     www.medigraphic.com